Discover 625 paid clinical trials in Arkansas. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Arkansas offers a variety of research opportunities for both healthy volunteers interested in paid clinical studies and individuals seeking trials for specific health conditions. Major research centers in Little Rock, Fayetteville, and Fort Smith are actively recruiting participants, providing access to advanced treatments and innovative medical care.
Filter
1
Filter results
Results: 625
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
for
Schizophrenia
Location: Boston MA, Watertown MA, Cedarhurst NY, The Bronx NY,
Sponsor: MapLight Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07459647
Phase 2, Recruiting
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
for
Atrial Fibrillation
Location: The Bronx NY, New York NY, Raleigh NC, Naples FL,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07523750
Recruiting
PBGENE-DMD Phase 1/2a Safety and Preliminary Efficacy Study in Duchenne Muscular Dystrophy (FUNCTION-DMD)
for
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD,
Location: St Louis MO, Little Rock AR
Sponsor: Precision BioSciences, Inc.
Sex: Male
Age: 2 - 7
Code: NCT07429240
Phase 1, Phase 2, Recruiting
Pharmacokinetics of Sulopenem Etzadroxil Plus Probenecid in Adolescents
for
Pharmacokinetics After Oral Intake
Location: Little Rock AR
Sponsor: Iterum Therapeutics, International Limited
Sex: All
Age: 12 - 17
Code: NCT07092813
Phase 1, Recruiting
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
for
Major Depressive Disorder (MDD)
Location: Cromwell CT, Brooklyn NY, New York NY, Marlton NJ,
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All
Age: 18 - 70
Code: NCT07226661
Phase 2, Recruiting
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
for
Bipolar I Disorder, Mania
Location: Marlton NJ, Gaithersburg MD, Little Rock AR, Houston TX,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18 - 65
Code: NCT07288320
Phase 2, Recruiting
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
for
Schizophrenia
Location: Boynton Beach FL, Miami Lakes FL, North Canton OH,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07363577
Phase 3, Recruiting
Dental-Child Interaction Training
for
Behavior and Behavior Mechanisms, Child Behavior
Location: Gainesville FL, Fayetteville AR
Sponsor: University of Florida
Sex: All
Age: 18 - 70+
Code: NCT06138405
Recruiting
Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing After Total Knee Arthroplasty (TKA)
for
Knee Osteoarthritis
Location: Little Rock AR
Sponsor: University of Arkansas
Sex: All
Age: 50 - 70+
Code: NCT05823727
Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Halifax, Boston MA, Farmington CT, New Haven CT,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, White Plains NY, Schenectady NY, Montreal,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States
for
Non-Muscle Invasive Bladder Neoplasms
Location: Bryn Mawr PA, Syracuse NY, North Charleston SC,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07309445
Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Boston MA, Lebanon NH, Quebec, Lake Success NY,